Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Kan Chen

Partner

Liwen Chen

Associate

Nan Chen

Principal

David Chu

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Associate

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho Ph.D

Venture Partner

William Hu

Managing Partner

Duane Kuang

Founding Managing Partner

Nisa Leung

Managing Partner

Lisa Li

Investor

Dingzheng Li

Vice President

Jing Liu

Associate

Chang Liu

Associate

Bin Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will Mcconnell

Principal

Mark McDade

Co-Founder and Managing Partner

Gary Rieschel

Founder and Managing Partner

Motao Sun

Associate

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Rachel Wang

Venture Partner

Xin Wang

Investor

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Kuantai Yeh

Partner

Peter (Ming) Yin

Principal, Cleantech

Janet Yu Ph.D

Partner

Liang Yuyu

Managing Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Investor

Zhifeng Zhou

Managing Partner

Yiqing Zhu

Associate

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in TMT

LTZ Therapeutics

Seed Round in 2022
LTZ Therapeutics is engaged in the development of innovative immunotherapies aimed at treating patients with cancer and other diseases that currently lack effective treatment options. The company employs reverse translational science and tumor biology, integrating these approaches with machine learning to advance its immunotherapy solutions. This strategy enables LTZ Therapeutics to create novel cancer treatments that address significant unmet clinical needs, ultimately striving to improve patient outcomes in the field of oncology.

moodytiger

Series B in 2021
Moody Tiger is an international activewear brand established in 2018, focusing on functional and fashionable athleisurewear for children aged 4 to 14 years. The company specializes in developing high-tech fabrics that ensure comfort and quality, catering to the needs of active children. By combining style with practicality, Moody Tiger aims to provide a range of fashion-forward activewear options that appeal to both children and their parents.

Cool Math

Series A in 2018
Founded in January 2018, Beijing Tianfutong Education Technology Co., Ltd. is an excellent technical and operational talent from education companies such as New Oriental, Good Future, and Gaosi, as well as outstanding technical talents from Internet companies such as Baidu, Sohu, and Meituan. Founded a new online education brand. Based on original quality education content and technology-driven, we provide high-quality online mathematics thinking learning content and services for children aged 3-12.

WindMIL Therapeutics

Series B in 2018
WindMIL Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies for cancer patients, utilizing insights from bone marrow immunology. Established in 2015 and based in Princeton, New Jersey, the company specializes in a novel class of therapies known as Marrow Infiltrating Lymphocytes (MILs). These therapies are derived from memory T cells found in the bone marrow and involve reactivating dormant T-cells to create effective immunotherapies. By harnessing the unique immunologic properties of bone marrow, WindMIL Therapeutics aims to provide life-saving treatment options for individuals battling cancer.

KingTrol Data

Series A in 2016
KingTrol

JHT TCM Clinics

Series B in 2016
JHT TCM Clinics

SMTP Technology

Series A in 2016
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.

SMTP Technology

Series A in 2015
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.

JHT TCM Clinics

Series A in 2013
JHT TCM Clinics

Timesafer

Series A in 2012
Timesafer is an electronic authentication and information security service provider that provides dynamic password and password protection services through mobile phone secrets. The mobile phone secrets a set of 6-digit dynamic passwords every 60 seconds or 30 seconds through the smartphone screen to provide account services to the user.

Mutto Optronics

Venture Round in 2010
Mutto Optronics Corporation, founded in 2008 and headquartered in Taipei, Taiwan, is involved in the manufacture and sale of stainless steel kitchen utensils and refined cutlery sets. The company operates internationally, with a presence in the United States, China, and Taiwan. In addition to its core business in cutlery, Mutto Optronics also produces touch display panels for the mobile phone and tablet markets, offering both resistive and capacitive technologies. The organization engages in original equipment manufacturing and original design manufacturing within the knife industry, contributing to its diverse revenue streams.

Tigermed

Venture Round in 2010
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization that specializes in providing comprehensive clinical trial services for pharmaceutical product research and development. Established to assist clients in minimizing the risks and costs associated with R&D, Tigermed offers a range of services including bioanalytical testing, medical writing, biostatistics analysis, and medical imaging. The company operates globally, with 21 subsidiaries in 43 major cities, including locations in China, the United States, Canada, Japan, Australia, and South Korea. Its professional team consists of over 900 employees dedicated to adhering to international operational standards. Tigermed has successfully delivered clinical trial services to more than 300 clients across various therapeutic areas, including infections, hematology, cardiovascular conditions, endocrinology, rheumatology, nephrology, and central nervous system disorders. Recognized as an “Innovation-type CRO,” Tigermed has played a significant role in the development of numerous domestic drugs.

Taomee

Series A in 2009
Taomee Holdings Limited is a children's entertainment and media company in China that aims to create exceptional entertainment experiences for children that are fun, safe, and trusted by parents. It leverages content development capability, professional knowledge of designing virtual worlds, and broad operating experience in Chinese children's entertainment market to develop memorable and iconic characters, images, and storylines that have attracted a loyal following among children between the ages of 5 and 15. Today, Mole's World and Seer stories and characters have reached more than 100 million children through Taomee’s award-winning online communities, 61.com. Taomee was founded in October 2007 and is headquartered in Shanghai. It received its first round of overseas investments of US$5 million from Sequoia Capital in June 2009. In June 2011, Taomee completed an initial public offering on the New York Stock Exchange, becoming the first Chinese children-themed stock to go public in the U.S.

T4GAME

Series A in 2008
Beijing T4game Network Technology Co., Ltd. develops and operates mobile games. The company was founded in 2008 and is based in Beijing, China.

Tigermed

Series A in 2008
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization that specializes in providing comprehensive clinical trial services for pharmaceutical product research and development. Established to assist clients in minimizing the risks and costs associated with R&D, Tigermed offers a range of services including bioanalytical testing, medical writing, biostatistics analysis, and medical imaging. The company operates globally, with 21 subsidiaries in 43 major cities, including locations in China, the United States, Canada, Japan, Australia, and South Korea. Its professional team consists of over 900 employees dedicated to adhering to international operational standards. Tigermed has successfully delivered clinical trial services to more than 300 clients across various therapeutic areas, including infections, hematology, cardiovascular conditions, endocrinology, rheumatology, nephrology, and central nervous system disorders. Recognized as an “Innovation-type CRO,” Tigermed has played a significant role in the development of numerous domestic drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.